Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Norris Medicines Ltd Stock Analysis

Small Cap
Evaluated by 15 users | BSE: 524414 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 00.96%0.31%-8.4%-4.9%3.5%-2.2%-13.99%-8.35%-14.8%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 015.721.420.718.718.920.513.616.37.815
Y-o-Y Gr. Rt.-NA36.6%-3.4%-9.8%1%8.5%-33.7%19.9%-51.8%-
Adjusted EPS (Rs.) 00.080.02-1.52-1.05-0.01-0.74-2.53-1.68-2.84-4.76
Y-o-Y Gr. Rt.-NA-75%-7700%NANANANANANA-
Book Value per Share (Rs.) 07.957.866.45.335.374.62.060.38-2.49-7.41
Adjusted Net Profit 00.10-1.5-1.10-0.7-2.5-1.7-2.8-5
Net Op. Cash Flow (Rs. Cr.) 00.3-0.61.40.71.4-10.8-1.9-2.9-
Debt to Cash Flow from Ops 015.36-12.625.2312.155.57-11.7314.2-7.42-6.21-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Norris Medicines Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NA-15.9%-27.4%-51.8%
Adjusted EPS NANANANA
Book Value per Share 0-185.9-181.5-755.3
Share Price - - 30.6% 184.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) 010.29-21.45-17.97-0.18-14.89-76.52-138.44271.1596.16
Operating Profit Margin (%) 010.75.33-5.129.134.430.02-14.14-3.77-27.48-7.95
Net Profit Margin (%) 00.50.11-7.33-5.6-0.05-3.6-18.64-10.31-36.22-31.11
Debt to Equity 00.660.91.191.541.412.475.5238.16-7.26-
Working Capital Days 00163192173159164254194396-
Cash Conversion Cycle 00536551677310659197-
Loading price chart...
Entity Percentage Holding
Promoters 34.04%
Institutions 0.07%
Non-Institutions 65.89%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Data is not available for this company.

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback